115 related articles for article (PubMed ID: 17224994)
1. Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi messenger RNAs.
Barbosa CF; Okuda ES; Chung MC; Ferreira EI; Cicarelli RM
Braz J Med Biol Res; 2007 Jan; 40(1):33-9. PubMed ID: 17224994
[TBL] [Abstract][Full Text] [Related]
2. Trypanosoma cruzi: establishment of permeable cells for RNA processing analysis with drugs.
Ambrósio DL; Barbosa CF; Vianna VF; Cicarelli RM
Mem Inst Oswaldo Cruz; 2004 Oct; 99(6):617-20. PubMed ID: 15558173
[TBL] [Abstract][Full Text] [Related]
3. Trypanosoma cruzi: evaluation of (-)-cubebin derivatives activity in the messenger RNAs processing.
Andrade e Silva ML; Cicarelli RM; Pauletti PM; Luz PP; Rezende KC; Januário AH; da Silva R; Pereira AC; Bastos JK; de Albuquerque S; Magalhães LG; Cunha WR
Parasitol Res; 2011 Aug; 109(2):445-51. PubMed ID: 21327990
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro evaluation of potential antichagasic hydroxymethylnitrofurazone (NFOH-121): a new nitrofurazone prodrug.
Chung MC; Güido RV; Martinelli TF; Gonçalves MF; Polli MC; Botelho KC; Varanda EA; Colli W; Miranda MT; Ferreira EI
Bioorg Med Chem; 2003 Nov; 11(22):4779-83. PubMed ID: 14556793
[TBL] [Abstract][Full Text] [Related]
5. Cruzain inhibition by hydroxymethylnitrofurazone and nitrofurazone: investigation of a new target in Trypanosoma cruzi.
Trossini GH; Malvezzi A; T-do Amaral A; Rangel-Yagui CO; Izidoro MA; Cezari MH; Juliano L; Chin CM; Menezes CM; Ferreira EI
J Enzyme Inhib Med Chem; 2010 Feb; 25(1):62-7. PubMed ID: 20030510
[TBL] [Abstract][Full Text] [Related]
6. Image-Based In Vitro Screening Reveals the Trypanostatic Activity of Hydroxymethylnitrofurazone against
Scarim CB; Olmo F; Ferreira EI; Chin CM; Kelly JM; Fortes Francisco A
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203228
[TBL] [Abstract][Full Text] [Related]
7. Hydroxymethylnitrofurazone treatment in indeterminate form of chronic Chagas disease: Reduced intensity of tissue parasitism and inflammation-A histopathological study.
Scarim CB; de Andrade CR; da Rosa JA; Dos Santos JL; Chin CM
Int J Exp Pathol; 2018 Oct; 99(5):236-248. PubMed ID: 30320480
[TBL] [Abstract][Full Text] [Related]
8. Hydroxymethylnitrofurazone is active in a murine model of Chagas' disease.
Davies C; Marino Cardozo R; Sánchez Negrette O; Mora MC; Chung MC; Basombrío MA
Antimicrob Agents Chemother; 2010 Sep; 54(9):3584-9. PubMed ID: 20566772
[TBL] [Abstract][Full Text] [Related]
9. In vitro capping in Trypanosoma cruzi identifies and shows specificity for the spliced leader RNA and U-RNAs.
Zwierzynski TA; Buck GA
Nucleic Acids Res; 1990 Jul; 18(14):4197-206. PubMed ID: 2198536
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of hydroxymethylnitrofurazone and its parent drug nitrofurazone in rabbits.
Nogueira Filho MA; Padilha EC; Campos ML; Pontes Machado DV; Davanço MG; Pestana KC; Chin CM; Peccinini RG
Drug Metab Lett; 2013 Mar; 7(1):58-64. PubMed ID: 23957951
[TBL] [Abstract][Full Text] [Related]
11. Hepatotoxicity in mice of a novel anti-parasite drug candidate hydroxymethylnitrofurazone: a comparison with Benznidazole.
Davies C; Dey N; Negrette OS; Parada LA; Basombrio MA; Garg NJ
PLoS Negl Trop Dis; 2014 Oct; 8(10):e3231. PubMed ID: 25329323
[TBL] [Abstract][Full Text] [Related]
12. RNA-protein complexes mediate in vitro capping of the spliced-leader primary transcript and U-RNAs in Trypanosoma cruzi.
Zwierzynski TA; Buck GA
Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5626-30. PubMed ID: 1829524
[TBL] [Abstract][Full Text] [Related]
13. Trypanosoma cruzi: characterisation of the gene encoding tyrosine aminotransferase in benznidazole-resistant and susceptible populations.
Rego JV; Murta SM; Nirdé P; Nogueira FB; de Andrade HM; Romanha AJ
Exp Parasitol; 2008 Jan; 118(1):111-7. PubMed ID: 17678649
[TBL] [Abstract][Full Text] [Related]
14. The trypanocidal benzoxaborole AN7973 inhibits trypanosome mRNA processing.
Begolo D; Vincent IM; Giordani F; Pöhner I; Witty MJ; Rowan TG; Bengaly Z; Gillingwater K; Freund Y; Wade RC; Barrett MP; Clayton C
PLoS Pathog; 2018 Sep; 14(9):e1007315. PubMed ID: 30252911
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of Cyclophilin (TcCyP19) in Trypanosoma cruzi populations susceptible and resistant to benznidazole.
Rêgo JV; Duarte AP; Liarte DB; de Carvalho Sousa F; Barreto HM; Bua J; Romanha AJ; Rádis-Baptista G; Murta SM
Exp Parasitol; 2015 Jan; 148():73-80. PubMed ID: 25450774
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the spliced leader genes and transcripts in Trypanosoma cruzi.
McCarthy-Burke C; Taylor ZA; Buck GA
Gene; 1989 Oct; 82(1):177-89. PubMed ID: 2684773
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of lipoamide dehydrogenase gene in Trypanosoma cruzi populations susceptible and resistant to benznidazole.
Dos Santos PF; Moreira DS; Baba EH; Volpe CMO; Ruiz JC; Romanha AJ; Murta SMF
Exp Parasitol; 2016 Nov; 170():1-9. PubMed ID: 27567984
[TBL] [Abstract][Full Text] [Related]
18. Actively transcribing RNA polymerase II concentrates on spliced leader genes in the nucleus of Trypanosoma cruzi.
Dossin Fde M; Schenkman S
Eukaryot Cell; 2005 May; 4(5):960-70. PubMed ID: 15879530
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of hydroxymethylnitrofurazone, a promising new prodrug for Chagas' disease treatment.
Serafim EO; Silva AT; Moreno Ade H; Vizioli Ede O; Ferreira EI; Peccinini RG; Ribeiro ML; Chung MC
Antimicrob Agents Chemother; 2013 Dec; 57(12):6106-9. PubMed ID: 24080661
[TBL] [Abstract][Full Text] [Related]
20. Identification of a spliced leader RNA binding protein from Trypanosoma cruzi.
Xu P; Wen L; Benegal G; Wang X; Buck GA
Mol Biochem Parasitol; 2001 Jan; 112(1):39-49. PubMed ID: 11166385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
